Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

A Phase I/IIa clinical trial to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary efficacy of INR102 injection in patients with prostate cancer.

Participants needed: 55
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Yunhe Pharmaceutical (Tianjin) Co., LtdUpdated: Jan 7, 2026Locations: 2
Eligibility criteria

Willingly participate in this clinical trial, demonstrate a clear understanding... [+9]

Within six months prior to the first study treatment, subjects had received syst... [+14]

Read more
Status: Not yet recruiting

A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

A multicenter, open-label, prospective Phase III clinical trial to evaluate INR101 injection for PET/CT imaging in participants with suspected recurrent prostate cancer after radical treatment.

Participants needed: 110
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: Yunhe Pharmaceutical (Tianjin) Co., LtdUpdated: Apr 11, 2025Locations: 32
Eligibility criteria

Males aged ≥18 years old [+8]

Participants who are unable to complete the imaging as required [+7]

Read more
Status: Not yet recruiting

Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

A multicenter, open-label, prospective Phase III clinical trial to evaluate INR101 injection for PET/CT imaging in patients with Prostate Cancer

Participants needed: 240
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: Yunhe Pharmaceutical (Tianjin) Co., LtdUpdated: Apr 13, 2025Locations: 32
Eligibility criteria

Males aged ≥18 years old [+11]

Participants who are unable to complete the imaging as required [+9]

Read more